CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Health House International Limited is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Health House International Limited
Level 3, 101 St Georges Terrace
Phone: 089444 2444p:089444 2444 PERTH, WAS  6000  Australia
This company was Merged or Acquired on 5/8/2023.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Health House International Limited is an international distributor specializing in the distribution of medicinal cannabis products across Australasia, United Kingdom and Europe. The Company is a fully licensed and regulated specialized importer, exporter, consolidator and distributor of medicinal cannabis products, distributing medicinal cannabis products to pharmacies, prescribers, specialist medicinal cannabis clinics and researchers across Australasia. It supplies pharmacies, hospital, government departments, veterinarians and other wholesalers with medicinal cannabis and general pharmaceutical products across the United Kingdom and Europe. The Company also integrates education of patients and healthcare professionals in the use of medicinal cannabis as a core part of its activities and is developing digital tools to enable a holistic understanding of usage.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20226/30/2022Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board David C.Wheeler 3/19/2021 4/3/2020
Chief Financial Officer DanielRohr 4/3/2018 12/10/2015
Chief Technology Officer JustinPante 12/10/2015 12/10/2015
4 additional Officers and Directors records available in full report.

Business Names
Business Name
CanPharma GmbH
HHI
VPC
VPCDA

General Information
Outstanding Shares: 178,224,625 (As of 12/31/2022)
Shareholders: 1,771
Stock Exchange: ASX
Email Address: info@healthhouse.com.au


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 17, 2024